Shattuck Labs, Inc. (STTK) Financials

STTK Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 102.1 million 6.3 million
Dec. 31, 2025 91.0 million 8.6 million
Sept. 30, 2025 100.3 million 7.1 million
June 30, 2025 64.4 million 7.4 million

STTK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -13.4 million 2.4 million
Dec. 31, 2025 -8.5 million 1.6 million
Sept. 30, 2025 -9.0 million 1.8 million
June 30, 2025 -10.4 million 1.9 million

STTK Net Income

No data available :(

STTK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 90.4 million 2.0 million -
Dec. 31, 2025 78.1 million 1.6 million 2.4 million
Sept. 30, 2025 42.5 million 1.8 million 2.6 million
June 30, 2025 50.5 million - 3.0 million

STTK Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 112.2 million
Dec. 31, 2025 103.8 million
Sept. 30, 2025 72.2 million
June 30, 2025 51.0 million

STTK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 63000 10.9 million 4.6 million -
Dec. 31, 2025 - 9.1 million 4.3 million -
Sept. 30, 2025 71000 7.6 million 4.1 million -
June 30, 2025 - 8.7 million 4.4 million -

STTK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 891000
Dec. 31, 2025 - 906000
Sept. 30, 2025 1.0 million -
June 30, 2025 - 929000

STTK Revenue by Segment
Graph available only for paid members. Upgrade to see it.

STTK

Price: $7.43

52 week price:
0.71
8.33

Earnings Per Share: -0.56 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 37824

Market Capitalization: 337.7 million

Links: